Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Free Cash Flow: 2009-2025

Historic Free Cash Flow for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $55.4 million.

  • Prestige Consumer Healthcare's Free Cash Flow fell 18.28% to $55.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $255.5 million, marking a year-over-year increase of 0.32%. This contributed to the annual value of $243.3 million for FY2025, which is 1.64% up from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Free Cash Flow stood at $55.4 million, which was down 29.15% from $78.2 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Free Cash Flow registered a high of $78.2 million during Q2 2025, and its lowest value of $46.6 million during Q2 2023.
  • In the last 3 years, Prestige Consumer Healthcare's Free Cash Flow had a median value of $59.5 million in 2023 and averaged $61.2 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Free Cash Flow surged by 47.29% in 2021 and then decreased by 18.51% in 2023.
  • Prestige Consumer Healthcare's Free Cash Flow (Quarterly) stood at $64.1 million in 2021, then dropped by 17.06% to $53.1 million in 2022, then soared by 30.74% to $69.5 million in 2023, then decreased by 8.57% to $63.5 million in 2024, then dropped by 18.28% to $55.4 million in 2025.
  • Its Free Cash Flow was $55.4 million in Q3 2025, compared to $78.2 million in Q2 2025 and $58.4 million in Q1 2025.